- Home
- DOCU vs BAX Comparison
DOCU vs BAX Comparison
Compare DOCU & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCU
- BAX
- Stock Information
- Founded
- DOCU 2003
- BAX 1931
- Country
- DOCU United States
- BAX United States
- Employees
- DOCU N/A
- BAX 38000
- Industry
- DOCU EDP Services
- BAX Medical/Dental Instruments
- Sector
- DOCU Technology
- BAX Health Care
- Exchange
- DOCU Nasdaq
- BAX Nasdaq
- Market Cap
- DOCU 14.6B
- BAX 9.2B
- IPO Year
- DOCU 2018
- BAX N/A
- Fundamental
- Price
- DOCU $69.74
- BAX $17.90
- Analyst Decision
- DOCU Hold
- BAX Hold
- Analyst Count
- DOCU 17
- BAX 10
- Target Price
- DOCU $95.62
- BAX $27.00
- AVG Volume (30 Days)
- DOCU 2.3M
- BAX 7.9M
- Earning Date
- DOCU 12-04-2025
- BAX 10-30-2025
- Dividend Yield
- DOCU N/A
- BAX 3.78%
- EPS Growth
- DOCU N/A
- BAX N/A
- EPS
- DOCU 1.33
- BAX N/A
- Revenue
- DOCU $3,095,362,000.00
- BAX $11,023,000,000.00
- Revenue This Year
- DOCU $9.55
- BAX $5.72
- Revenue Next Year
- DOCU $6.78
- BAX $2.52
- P/E Ratio
- DOCU $52.25
- BAX N/A
- Revenue Growth
- DOCU 8.29
- BAX 3.90
- 52 Week Low
- DOCU $66.35
- BAX $17.47
- 52 Week High
- DOCU $107.86
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- DOCU 43.93
- BAX 20.23
- Support Level
- DOCU $68.31
- BAX $17.47
- Resistance Level
- DOCU $74.25
- BAX $18.16
- Average True Range (ATR)
- DOCU 2.18
- BAX 0.56
- MACD
- DOCU 0.19
- BAX -0.45
- Stochastic Oscillator
- DOCU 22.91
- BAX 7.81
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in 2018.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.